Advertisement

Topics

GammaAminobutyric Acid Receptor Subunit Alpha 5 GABAA Receptor Subunit Alpha 5 or GABRA5 Pipeline Review, H1 2018 [Report Updated: 12062018] Prices from USD $3500

22:51 EDT 7 Aug 2018 | BioPortfolio Reports

GammaAminobutyric Acid Receptor Subunit Alpha 5 GABAA Receptor Subunit Alpha 5 or GABRA5 Pipeline Review, H1 2018


Summary


According to the recently published report 'GammaAminobutyric Acid Receptor Subunit Alpha 5 Pipeline Review, H1 2018'; GammaAminobutyric Acid Receptor Subunit Alpha 5 GABAA Receptor Subunit Alpha 5 or GABRA5 pipeline Target constitutes close to 10 molecules. Out of which approximately 8 molecules are developed by companies and remaining by the universities/institutes.


GammaAminobutyric Acid Receptor Subunit Alpha 5 GABAA Receptor Subunit Alpha 5 or GABRA5 Gammaaminobutyric acid A receptor, alpha 5 or GABRA5 is a protein encoded by the GABRA5 gene. It mediates neuronal inhibition by binding to the GABA/benzodiazepine receptor and opening an integral chloride channel.


The report 'GammaAminobutyric Acid Receptor Subunit Alpha 5 Pipeline Review, H1 2018' outlays comprehensive information on the GammaAminobutyric Acid Receptor Subunit Alpha 5 GABAA Receptor Subunit Alpha 5 or GABRA5 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action MoA, route of administration RoA and molecule type; that are being developed by Companies / Universities.


It also reviews key players involved in GammaAminobutyric Acid Receptor Subunit Alpha 5 GABAA Receptor Subunit Alpha 5 or GABRA5 targeted therapeutics development with respective active and dormant or discontinued projects. Currently, The molecules developed by companies in Phase II, Phase I and Preclinical stages are 2, 2 and 4 respectively. Similarly, the universities portfolio in Preclinical stages comprises 2 molecules, respectively. Report covers products from therapy areas Central Nervous System, Cardiovascular and Genetic Disorders which include indications Autism, Alzheimer's Disease, Cognitive Disorders, Cognitive Impairment, Cognitive Impairment Associated With Schizophrenia CIAS, Depression, Down Syndrome, Ischemic Cerebral Stroke, Mild Cognitive Impairment, Pervasive Developmental Disorder PDD, Schizophrenia and Traumatic Brain Injury.


Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.


Scope


The report provides a snapshot of the global therapeutic landscape for GammaAminobutyric Acid Receptor Subunit Alpha 5 GABAA Receptor Subunit Alpha 5 or GABRA5

The report reviews GammaAminobutyric Acid Receptor Subunit Alpha 5 GABAA Receptor Subunit Alpha 5 or GABRA5 targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industryspecific sources

The report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, RD brief, licensing and collaboration details other developmental activities

The report reviews key players involved in GammaAminobutyric Acid Receptor Subunit Alpha 5 GABAA Receptor Subunit Alpha 5 or GABRA5 targeted therapeutics and enlists all their major and minor projects

The report assesses GammaAminobutyric Acid Receptor Subunit Alpha 5 GABAA Receptor Subunit Alpha 5 or GABRA5 targeted therapeutics based on mechanism of action MoA, route of administration RoA and molecule type

The report summarizes all the dormant and discontinued pipeline projects

The report reviews latest news and deals related to GammaAminobutyric Acid Receptor Subunit Alpha 5 GABAA Receptor Subunit Alpha 5 or GABRA5 targeted therapeutics


Reasons to buy


Gain strategically significant competitor information, analysis, and insights to formulate effective RD strategies

Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage

Identify and understand the targeted therapy areas and indications for GammaAminobutyric Acid Receptor Subunit Alpha 5 GABAA Receptor Subunit Alpha 5 or GABRA5

Identify the use of drugs for target identification and drug repurposing

Identify potential new clients or partners in the target demographic

Develop strategic initiatives by understanding the focus areas of leading companies

Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding GammaAminobutyric Acid Receptor Subunit Alpha 5 GABAA Receptor Subunit Alpha 5 or GABRA5 development landscape

Develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Original Article: GammaAminobutyric Acid Receptor Subunit Alpha 5 GABAA Receptor Subunit Alpha 5 or GABRA5 Pipeline Review, H1 2018 [Report Updated: 12062018] Prices from USD $3500

NEXT ARTICLE

More From BioPortfolio on "GammaAminobutyric Acid Receptor Subunit Alpha 5 GABAA Receptor Subunit Alpha 5 or GABRA5 Pipeline Review, H1 2018 [Report Updated: 12062018] Prices from USD $3500"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...